These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6330841)

  • 1. Elimination of poliomyelitis in Finland.
    Lapinleimu K
    Rev Infect Dis; 1984; 6 Suppl 2():S457-60. PubMed ID: 6330841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences with polio vaccination and herd immunity in Finland.
    Lapinleimu K; Stenvik M
    Dev Biol Stand; 1981; 47():241-6. PubMed ID: 6262149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.
    Gudnadóttir M
    Dev Biol Stand; 1981; 47():257-9. PubMed ID: 7227654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.
    Herremans MM; van Loon AM; Reimerink JH; Rümke HC; van der Avoort HG; Kimman TG; Koopmans MP
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):499-503. PubMed ID: 9302194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus.
    Böttiger M
    Rev Infect Dis; 1984; 6 Suppl 2():S548-51. PubMed ID: 6740100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of poliomyelitis by vaccination in Belgium.
    André FE
    Rev Infect Dis; 1984; 6 Suppl 2():S419-23. PubMed ID: 6740084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and control of poliomyelitis in The Netherlands.
    Bijkerk H
    Rev Infect Dis; 1984; 6 Suppl 2():S451-6. PubMed ID: 6330840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
    Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity induced by inactivated poliovirus vaccine and excretion of virus.
    Chin TD
    Rev Infect Dis; 1984; 6 Suppl 2():S369-70. PubMed ID: 6330838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis vaccines (Td-IPV or DT-IPV) and immune responses to a booster dose of DTaP-IPV.
    Gajdos V; Vidor E; Richard P; Tran C; Sadorge C
    Vaccine; 2015 Jul; 33(32):3988-96. PubMed ID: 26087294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations.
    Salk D
    Rev Infect Dis; 1980; 2(2):258-73. PubMed ID: 6994208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population.
    Hovi T; Cantell K; Huovilainen A; Kinnunen E; Kuronen T; Lapinleimu K; Pöyry T; Roivainen M; Salama N; Stenvik M
    Lancet; 1986 Jun; 1(8495):1427-32. PubMed ID: 2872526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinology of poliomyelitis.
    Salk D; Salk J
    Vaccine; 1984 Mar; 2(1):59-74. PubMed ID: 6099644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
    Embree J; Law B; Voloshen T; Tomovici A
    Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.